Info
Ownership

Ronald C. Renaud JR - Insider Trading & Ownership

Location: C/O Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge, MA
Summary: The estimated net worth of Ronald C. Renaud JR is at least $12.3K dollars as of June 12, 2025. Ronald C. Renaud JR is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $12.3K.
Signature: /s/ Allison Ambrose, Attorney-in-Fact
All Insider Reports: All Insider Reports

Ownership of Ronald C. Renaud JR

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ATRA	Atara Biotherapeutics, Inc.	Director	$12.3K			Jun 23, 2022
CERE	Cerevel Therapeutics Holdings, Inc.	President & CEO, Director	$0			Aug 1, 2024
IKNA	Ikena Oncology, Inc.	Director				Jun 9, 2022
TBIO	Translate Bio, Inc.	Chief Executive Officer, Director				Sep 14, 2021
UPB	Upstream Bio, Inc.	Director				Jun 10, 2025

Showing 1 to 5 of 5 entries

Insider Transactions Reported by Ronald C. Renaud JR:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.